MedPath

Combined Package of Interventions for Environmental Enteropathy

Not Applicable
Completed
Conditions
Environmental Enteropathy
Interventions
Drug: Placebo
Dietary Supplement: Zinc
Dietary Supplement: Multiple Micronutrient Supplement
Registration Number
NCT02253095
Lead Sponsor
Washington University School of Medicine
Brief Summary

Randomized, double-blind, placebo controlled trial of a combined intervention of zinc, albendazole, and multiple micronutrients in improving environmental enteropathy in Malawian children.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
253
Inclusion Criteria
  • children residing in catchment area of Limela, Machinga District, Malawi
  • aged 12-35 months
  • youngest eligible child in each household
Exclusion Criteria
  • severe acute malnutrition
  • severe chronic illness
  • children unable to drink 20 mL of dual sugar solution
  • children in need of acute medical treatment for illness or injury at time of enrollment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Multiple Intervention ArmZincsingle dose albendazole, two weeks of zinc, 24 weeks of multiple micronutrients
Multiple Intervention ArmMultiple Micronutrient Supplementsingle dose albendazole, two weeks of zinc, 24 weeks of multiple micronutrients
PlaceboPlacebothree placebos
Multiple Intervention ArmAlbendazolesingle dose albendazole, two weeks of zinc, 24 weeks of multiple micronutrients
Primary Outcome Measures
NameTimeMethod
Dual Sugar Absorption Test24 weeks

lactulose-mannitol ratio in urine

Secondary Outcome Measures
NameTimeMethod
Lactulose Excretion24 weeks

percentage of ingested lactulose excreted in urine

Mannitol Excretion24 weeks

percentage of ingested mannitol excreted in urine

Trial Locations

Locations (1)

Limela Rural Site

🇲🇼

Limela, Machinga Distric, Malawi

© Copyright 2025. All Rights Reserved by MedPath